Abbott Labs's most recent trend suggests a bullish bias. One trading opportunity on Abbott Labs is a Bull Put Spread using a strike $41.00 short put and a strike $36.00 long put offers a potential 5.71% return on risk over the next 26 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $41.00 by expiration. The full premium credit of $0.27 would be kept by the premium seller. The risk of $4.73 would be incurred if the stock dropped below the $36.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Abbott Labs is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Abbott Labs is bullish.
The RSI indicator is at 55.27 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Abbott Labs
Amgen Q3 Earnings Beat Estimates; Guidance Mixed
Mon, 27 Oct 2014 22:56:00 GMT
Here's what companies were saying about the economy this week
Fri, 24 Oct 2014 14:16:10 GMT
Abbott Laboratories (ABT) Earnings Report: Q3 2014 Conference Call Transcript
Thu, 23 Oct 2014 15:57:00 GMT
[$$] Abbott Sales Rise 5.8%; Mylan Terms Revised
Thu, 23 Oct 2014 04:51:25 GMT
The Wall Street Journal – Abbott tweaked the terms of its agreement to sell a portion of its generic-drugs business to Mylan for $5.3 billion, signaling the deal will be completed despite new Treasury department rules.
Biogen, Thermo Reports Disappoint; Abbott Accelerates
Wed, 22 Oct 2014 22:43:00 GMT
Also on Market Tamer…
Follow Us on Facebook